| Net Cash Provided by (Used in) Operating Activities |
-70.9K |
USD |
+56.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
173K |
USD |
+33.1% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
10M |
shares |
-50% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
9.09M |
shares |
-49.4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
29.9K |
USD |
|
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
11.2K |
USD |
-64.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
3.99K |
USD |
-5.4% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
-44.8K |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
3.79M |
USD |
+1.02% |
Q3 2023 |
Q3 2023 |
| Deferred Federal Income Tax Expense (Benefit) |
-18K |
USD |
-140% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
24.9M |
USD |
+0.7% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
85.6K |
USD |
+140% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.14M |
USD |
+1.24% |
Q3 2023 |
Q3 2023 |
| Deferred State and Local Income Tax Expense (Benefit) |
-7.7K |
USD |
-140% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
25.4K |
USD |
+40.7% |
Q3 2025 |
Q3 2025 |